Patterns of clinical use of omalizumab in Spain: A 5-year "real-life" study

L. Pérez de Llano, J. M. Zubeldia, L. Herráez (Lugo, Madrid, Barcelona, Spain)

Source: International Congress 2014 – Intervening in allergic asthma
Session: Intervening in allergic asthma
Session type: Poster Discussion
Number: 3476
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Pérez de Llano, J. M. Zubeldia, L. Herráez (Lugo, Madrid, Barcelona, Spain). Patterns of clinical use of omalizumab in Spain: A 5-year "real-life" study. Eur Respir J 2014; 44: Suppl. 58, 3476

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of omalizumab in Polish real-world patients
Source: International Congress 2016 – Asthma management
Year: 2016


Modern allergy diagnostics in China: The past and present
Source: International Congress 2014 – Clinical allergy
Year: 2014

Features of asthma treatment while pregnancy
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Five-year clinical study of children with atopic asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Evaluating omalizumab persistency of response after long-term therapy (XPORT)
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Cohort study of patients with asthma and immunodeficiency
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


Omalizumab reduces exacerbations and healthcare utilisation in severe allergic asthma patients UK clinical practice - APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Development of binary forecast models of asthma exacerbation: Asthma index
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016

Are curly horses an alternative for horse allergic riders?
Source: International Congress 2014 – Clinical allergy
Year: 2014


Asthma clusters in a real asthmatic population, treated in secondary medical care
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

The clinical and genetic factors for predicting the response to inhaled corticosteroids
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014

The results of the immunomorphological study of the placenta in women with asthma
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014


The impact of sublingual allergen-specific therapy on asthma control and quality of life
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Study of psychiatric comorbidities in patients with bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


Association between control of rhinitis and control of asthma as assessed by validated questionnaires
Source: International Congress 2014 – Clinical allergy
Year: 2014

Radioallergosorbant testing – A Southern Saskatchewan experience
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013


Asthma in the elderly: Clinical findings
Source: Annual Congress 2013 –Asthma
Year: 2013